Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial-Reference-Cited by-同舟云学术

Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial

Published:2018-10-16 Issue:5 Volume:54 Page:388-395
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Schmelz Renate^ORCID,Miehlke Stephan,Thiede Christian,Brueckner Stefan,Dawel Monic,Kuhn Matthias,Ruskoné-Formestraux Agnes,Stolte Manfred,Jentsch Christina,Hampe Jochen,Morgner Andrea

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00535-018-1517-4.pdf

Reference29 articles.

1. Fischbach W. Gastric MALT lymphoma—update on diagnosis and treatment. Best Pract Res Clin Gastroenterol. 2014;28:1069–77.

2. Musshoff K. Clinical staging classification of non-Hodgkin’s lymphomas. Strahlentherapie. 1977;153:218–21.

3. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628–38.

4. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61:507–13.

5. Fischbach W, Goebeler-Kolve M-E, Dragosics B, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004;53:34–7.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori?;JCO Oncology Practice;2024-08

2. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial;The Lancet Haematology;2024-07

3. How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology;Current Oncology;2024-06-17

4. Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View;Cancers;2023-07-27

5. Outcome of Hypofractionated Radiotherapy for Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma;Anticancer Research;2023-07-26